Stock screener

RARE

Conviction 72HealthcareScan · Mon, Jul 20, 2026
Bearish engulfing
RARE$28.52-2.61%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
Vol MA14 2.35M
Apr 20May 6May 26Jun 11Jul 1Jul 20
Ultragenyx Pharmaceutical Inc.PHARMACEUTICAL PREPARATIONSwww.ultragenyx.com
Price28.52
Change-2.61%
Gap+1.13%
Rel volume0.96×
Avg volume3.09M
Avg $ vol98.02M
SMA 2031.72
SMA 5027.21
SMA 20027.21
Price vs 50+4.80%
Price vs 200+4.80%
MA stackbullish
50/200 crossgolden · 0d
Supertrenddown · 34.25
RSI (14)43
MACD hist-0.79
MACD crossbear · 4d
Stoch %K / %D0 / 6
ADX (14)42
+DI / −DI24 / 22
RSI divergence
MACD divergence
ATR %+5.69%
ADR %5.19%
52w high36.54
52w low18.50
From 52w high-21.96%
Above 52w low+54.14%
New 52w highNo
SqueezeOff
Bollinger width28.28%
%B0.14
Donchian pos11.29%
Donchian high36.57
Donchian low27.49
AVWAP (52w high)25.04
vs AVWAP high+13.87%
AVWAP (52w low)26.45
vs AVWAP low+7.82%
OBV trendUp
Chaikin MF (20)0.17
Today vs 20d0.96×
Avg vol (14d)2.35M
Avg vol (20d)3.09M
Avg $ vol (20d)98.02M
Market cap2.81B
RS 3m (vs SPY)+13.48%
RS 6m (vs SPY)+13.98%
RS line new highNo
Trend template6/8
Technical rank69.1
1 week-14.16%
1 month+5.96%
3 months+14.93%
6 months+21.34%
1 year+4.03%
YTD+20.83%
P/E-4.88
P/B-11.90
P/S4.17
P/FCF-5.95
EPS-5.83
Div yield
ROE243.64%
ROA-44.37%
Debt/Eq
Current2.02
EV/EBITDA-5.27
Gross margin
Net margin-85.44%
Rev growth20.18%
EPS growth-1.05%
Price target54.00
Target upside89.37%
Analyst ratingBuy
Institutional110.51%
Ent. value2.63B
Revenue136M
Net income-185M
Gross profit
Free cash flow-472M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out98.49M
Employees1.37K
ListedFri, Jan 31, 2014
Free float91.5M
Float %94.9%
Short interest16.22M
Days to cover3.6d
Short volume37.1%
Squeeze score53 / 100
Next earnings
EPS forecast
Last EPS vs est−$1.84 vs −$1.55
Last surprise-18.7% miss
Setup gradeB
Conviction72 / 100
Pattern quality
Tech rank69.1 / 100
Group rank23 / 100
Status lane
Setup direction
Pattern family
Resistance
Support
Days since event
Candle confirmBearish engulfing
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in RARE · 3 recent

All disclosures →
MemberSideAmount
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2026-03-03
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-08-08
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-07-15
Buy$1K–$15K

Insider activity

SEC Form 4 transactions in RARE · 8 buys · 2 sells

InsiderSideShares
Horn Howard
Chief Financial Officer · Common Stock · 2026-06-01
Sell4.65K
SULIMAN SHEHNAAZ
Director · Common Stock · 2026-05-18
Sell5.74K
WELCH DANIEL G
Director · Common Stock · 2026-05-14
Grant7.75K
Dunsire Deborah
Director · Common Stock · 2026-05-14
Grant7.75K
Sanders Corazon (Corsee) D.
Director · Common Stock · 2026-05-14
Grant7.75K
Fust Matthew K
Director · Stock Option (Right to Buy) · 2026-05-14
Grant14.06K
Ray Amrit
Director · Common Stock · 2026-05-14
Grant7.75K
Fust Matthew K
Director · Common Stock · 2026-05-14
Grant7.75K
WELCH DANIEL G
Director · Stock Option (Right to Buy) · 2026-05-14
Grant14.06K
NARACHI MICHAEL
Director · Common Stock · 2026-05-14
Grant7.75K

SEC filings

EDGAR filings in RARE · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.